Skip to main content
Signal8

ForGrowth NAP B.V.

SEC insider (Form 3/4/5 filer). CIK 0002005407. 10% Owner at NewAmsterdam Pharma Co N.V. (NAMS). 25 reported Form 4/5 transactions since Sep 2024; latest on Dec 30, 2024. Located in NAARDEN, P7.

Companies ForGrowth NAP B.V. has filed insider reports for

  • NewAmsterdam Pharma Co N.V. (NAMS): 10% Owner
ForGrowth NAP B.V. profile photo

ForGrowth NAP B.V.

CIK: 0002005407

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)25 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NewAmsterdam Pharma Co N.V. logo
NAMS

NewAmsterdam Pharma Co N.V.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (25 total)

  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 30, 2024
    Sale
    Indirect
    29.8K shares at avg. $25.54$762K
  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 27, 2024
    Sale
    Indirect
    41.5K shares at avg. $25.95$1.1M
  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 26, 2024
    Sale
    Indirect
    33.4K shares at avg. $26.01$870K
  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 24, 2024
    Sale
    Indirect
    16.2K shares at avg. $25.66$415K
  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 23, 2024
    Sale
    Indirect
    25.1K shares at avg. $25.49$641K
  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 20, 2024
    Sale
    Indirect
    44.1K shares at avg. $25.53$1.1M
  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 20, 2024
    Sale
    Indirect
    5.6K shares at avg. $26.13$147K
  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 19, 2024
    Sale
    Indirect
    56.5K shares at avg. $25.45$1.4M
  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 18, 2024
    Sale
    Indirect
    46.2K shares at avg. $26.55$1.2M
  • NewAmsterdam Pharma Co N.V. logo
    NAMS

    NewAmsterdam Pharma Co N.V.

    Dec 18, 2024
    Sale
    Indirect
    54.5K shares at avg. $25.72$1.4M

1-10 of 25